KMT2D and hematologic disorder: Although the occurrence of recurrent mutations affecting MLL4 has been well documented in solid tumors, hematological malignancies, and Kabuki syndrome, the mechanisms by which MLL4 mutation lesions drive oncogenesis and disease progression remain elusive.